DKCM
MNTA

Davidson Kempner Capital Management’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Davidson Kempner Capital Management’s Portfolio MNTA Stock Details MNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-600,000
Closed -$31.5M – 387
2020
Q3 		$31.5M Buy
+600,000
New +$24.8M 0.45% 53

Davidson Kempner Capital Management's MNTA Position: Q4 2020 in Review

Davidson Kempner Capital Management sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2020, closing a stake of 600,000 shares — an estimated $31.5M sold.

Davidson Kempner Capital Management first reported a position in MNTA in Q3 2020 and held it in 1 quarter. The position peaked at $31.5M in Q3 2020. 0 funds tracked by Wall St. Rank hold MNTA as of Q4 2020.

  • Davidson Kempner Capital Management reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
  • Davidson Kempner Capital Management sold 600,000 Momenta Pharmaceuticals, Inc. shares in Q4 2020, an estimated $31.5M.
  • Davidson Kempner Capital Management first reported a position in Momenta Pharmaceuticals, Inc. in Q3 2020 and held it in 1 quarter.
  • Davidson Kempner Capital Management's Momenta Pharmaceuticals, Inc. position peaked at $31.5M in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2020.

Based on Davidson Kempner Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.